Barclays’s HCW Biologics HCWB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-191
Closed -$953 – 5532
2026
Q2
$953 Buy
+191
New +$1.08K ﹤0.01% 4934

Other funds holding HCWB

Barclays's HCWB Position: Q3 2026 in Review

Barclays sold out of HCW Biologics (HCWB) in Q3 2026, closing a stake of 191 shares — an estimated $953 sold.

Barclays first reported a position in HCWB in Q2 2026 and held it in 1 quarter. The position peaked at $953 in Q2 2026. 12 funds tracked by Wall St. Rank hold HCWB as of Q3 2026.

  • Barclays reported no remaining HCW Biologics position as of Q3 2026 after selling out during the quarter.
  • Barclays sold 191 HCW Biologics shares in Q3 2026, an estimated $953.
  • Barclays first reported a position in HCW Biologics in Q2 2026 and held it in 1 quarter.
  • Barclays's HCW Biologics position peaked at $953 in Q2 2026.
  • 12 funds tracked by Wall St. Rank held HCW Biologics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.